Previous Article | Next Article 
Journal of Clinical Microbiology, February 2000, p. 755-762, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Molecular Epidemiology of Rabies Virus Isolates
from Israel and Other Middle- and Near-Eastern Countries
D.
David,1,*
B.
Yakobson,1
J. S.
Smith,2 and
Y.
Stram3
Rabies Laboratory, Pathology
Division,1 and Virology
Division,3 Kimron Veterinary Institute, Bet
Dagan 50250, Israel, and Rabies Laboratory, Viral and
Rickettsial Zoonoses Branch, Division of Viral and Rickettsial
Diseases, National Centers for Infectious Diseases, Atlanta, Georgia
303332
Received 16 June 1999/Returned for modification 14 October
1999/Accepted 17 November 1999
 |
ABSTRACT |
A total of 226 isolates of rabies virus from different areas of
Israel, including three human isolates and one sample from South
Lebanon were identified between 1993 and 1998 by direct immunofluorescence using monoclonal antibodies to the viral
nucleoprotein (N). An epidemiological survey based on nucleotide
sequence analysis of 328 bp from the C terminus of the N coding region
and the noncoding region between the nucleoprotein and the
phosphoprotein (NS gene) was performed. Phylogenetic analysis of the
isolates from Israel showed that they were related geographically, but
not according to host species. Five variants, related groups
distributed among four geographical regions, were identified. In each
region, rabies virus was isolated from more than one animal species. A
comparison of the sequence analysis of rabies virus samples from the
rest of world revealed a 2-nucleotide change that distinguished the Middle East variants from the rest.
 |
INTRODUCTION |
Between 1949 and 1961, dogs and
cattle were the domestic animals most commonly affected by the rabies
virus and the jackal was so among wild animals (9).
Vaccination programs, mandatory in Israel since 1956, stopped the
domestic dog from being a reservoir for rabies virus but did not
eliminate rabies from the country. The jackal (Canis aureus)
was the first wildlife rabies virus vector to be recognized, but
extermination of the jackal population in the 1960s reduced its
importance as a virus reservoir. The reservoir for rabies virus
transmission now persists among wild canids, with occasional
transmission to human and domestic animals. Since 1979, the fox
(Vulpes vulpes) has been the most important reservoir
for rabies virus in Israel, and it was recently shown that between 1976 and 1997 foxes accounted for 46% of rabies virus cases whereas only
4% of cases could be traced to jackals (17). Rabies in
Israel is enzootic, and cumulative data from 50 years (1948 to 1997) on
its geographical distribution, analyzed by decade, showed that
different districts predominated at each interval, while no single
district predominated in the total number of cases. With the
development of an oral rabies virus vaccine for wildlife, control
efforts can now be focused on elimination of wild species serving as
reservoirs. Nevertheless, the success of control programs can be
predicted according to accurate identification of the species serving
as a maintenance reservoir within the particular region targeted in a
vaccination campaign and accurate determination of the patterns of
disease transmission within and between different regions, which might
suggest natural barriers to animal movement that can also be exploited
in a control program. Traditionally, assumptions about reservoir
maintenance were based solely on case surveillance data, which are
often subject to submission bias. Genetic analysis of rabies virus
isolates can circumvent this bias (e.g., more cases are reported in
zones of high human populations and cases are more frequently reported
among wild species with commensal habits). Patterns of virus evolution,
as evidenced by changes in nucleotide sequences, reflect independent
pathways of virus transmission indicative of virus population isolated by geography or animal host. In this paper we analyze rabies virus isolates collected from different regions of Israel. Patterns of virus
evolution are used to infer a molecular epidemiology that supports the
fox as the principal reservoir host for virus transmission and
identifies potential geographic barriers that separate fox populations
and interrupt disease transmission.
 |
MATERIALS AND METHODS |
Virus isolates.
Three human brains and 223 animal brains,
including one from South Lebanon, were submitted to the Pathology
Division, Kimron Veterinary Institute. All the samples were tested for
rabies virus by direct immunofluorescence antibody (dIFA) test
(Centocor, Malvern, Pa.) as described previously (10). The
species of origin of the samples from Israel and their geographic
origin are shown in Tables 1 and
2.
RNA extraction and RT-PCR.
Total RNA was extracted, using
TRI reagent (Molecular Research Center, Cincinnati, Ohio), from
infected brain tissue for PCR assay according to the manufacturer's
instructions. For reverse transcription (RT), RNA was heated to 95°C
for 1 min, cooled on ice, and added to 20 µl of a reverse
transcription reaction mixture containing avian myeloblastosis virus
(AMV) RT reaction buffer (25 mM Tris-HCl [pH of 8.3 at 42°C], 25 mM
KCl, 5 mM MgCl2, 5 mM ditheothreitol, 0.25 mM spermidine),
250 µM concentrations of each of four deoxynucleotides, 100 pmol of
specific primer 10 g (5'-CTACAATGGATGCCGAC-'3)
(11), 25 U of RNasin (Promega, Madison, Wis.), and 10 U of AMV reverse transcriptase (Promega). After incubation at 42°C
for 90 min, 1 µl of cDNA product was added to a 25-µl (total
volume) PCR mixture [60 mM Tris HCl, 15 mM
(NH4)2SO4, 1.5 mM MgCl2
(pH 8.5)] containing 100 µM concentrations of each of the four
nucleotides, Taq polymerase (5 U of Amplitaq; Perkin-Elmer),
and 100 ng each of primer 113 (5'-GTAGGATGATATATGGG-'3) (15) and primer 304 (5'-GAGTCACTCGAATATGTC-'3)
for PCR. Forty cycles of 45 s at 94°C, 45 s at
37°C, and 90 s at 72°C were programmed. The PCR product of 521 bp was analyzed on a 1.5% agarose gel containing ethidium bromide.
Genetic and computer analysis.
Genetic analysis was
performed on PCR products from the brains of humans and wild and
domestic animals. Analysis of the nucleic acid sequences was carried
out with the Pileup program, a part of the Genetics Computer Group
Wisconsin sequence analysis package (3). The 521-bp PCR
products of the N genes were purified (Wizard PCR prep DNA purification
system; Promega) and sequenced with an Applied Biosystems automatic
sequencer and one of the PCR primers. For the 521-bp sequence we used
NS primer 304 (genome position, nucleotides [nt] 1513 to 1533), which
was selected according to the Pasteur virus sequence (16).
The 328-bp sequences of the N carboxy-terminal nt 1156 to 1484 were
compared. This fragment contained 264 bp of the N gene and 64 bp of the
untranslated region between the N and NS genes. Fourteen isolates
originating from the Middle East, Europe, and Africa (6)
were studied and compared to the sequences of the isolates from Israel.
Nucleotide sequence accession numbers.
The nucleotide
sequences described in this report have been submitted to GenBank and
assigned the following accession numbers: variant I, AF162801 to
AF162807; variant II, AF162808 to AF162817; variant III, AF162818
to AF162827; variant IV, AF162828 to AF162830; and variant V,
AF162831 and AF162832.
 |
RESULTS |
Identification of rabies virus by dIFA and RT-PCR assays.
Brain tissues collected from 226 animals and humans dying from rabies
from 1993 to 1998 were distributed as follows (Table 2): 3 samples from 1993, 12 samples from 1995, 51 samples from 1996, 85 samples from 1997, and 75 samples from 1998. All samples were rabies
virus-positive by dIFA and RT-PCR assays.
Genetic analysis.
Overall, the virus samples from Israel
shared more than 97% nucleotide homology. According to patterns
of nucleotide substitution (Fig. 1 and
2) the 226 virus samples
were separated into five groups or genetic virus variants. With the
exception of variant V, inclusion of a virus isolate within a
group was based solely on its geographic origin (Fig.
3). All 57 isolates originating from the
Golan Heights region, regardless of animal species, were grouped as
variant I. Variant I revealed seven subgroups, designated A to G (Fig.
1), which were characterized by a change at nt 45 (T
C) (Fig. 2). The
83 isolates originating from Galilee were grouped as variant II.
Variant II contained 10 subgroups, 8 of which, A, B, C, D, E, F, I, and
J (Fig. 1), were characterized by a change at nt 180 (G
A) (Fig. 2).
Subgroup G was identical to the consensus sequence. Subgroup H had a
change at nt 146 (A
G) (Fig. 2). The 58 isolates originating from
central and southern areas of the country were grouped as variant III,
which is characterized by a change at nt 295 in the noncoding region
between the N and NS genes from C to T (Fig. 2). The 28 isolates
originating from Arava Valley were grouped as variant IV, with three
subgroups, A, B, and C (Fig. 1), characterized by changes at nt 248 (A
G) and nt 257 (T
C) (Fig. 2). Group V consisted of only two
samples, one from a dog and one from a cow, from the Golan Heights and Arava Valley, respectively; this variant was quite different from all
the other variants from Israel and differed in six positions (nt 55, 87, 156, 178, 272, and 281) (Fig. 2). All groups contained samples from
at least two different animal species.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Dendrogram showing the percentage of genetic relatedness
among Israeli rabies virus isolates, as determined by analysis of
328-bp sequence of the nucleoprotein gene. The numbers in parentheses
are the numbers of isolates in each subgroup.
|
|




View larger version (37353632K):
[in this window]
[in a new window]
|
FIG. 2.
Nucleotide sequence homology analysis of 226 Israeli
rabies virus isolates. Arrowheads indicate the positions of the
nucleotide substitutions characteristic of each sequence group.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Map of Israel showing the distribution of the five virus
variant groups (I to V) found in four geographical regions designated
regions 1 to 4 and defined as follows: region 1, Golan Heights; region
2, Galilee; region 3, Central-Southern area; and region 4, Arava
Valley.
|
|
Human rabies virus.
Three human rabies virus cases were
recently diagnosed in Israel within a 13-month period (2).
The first patient, a 20-year-old soldier in the Golan Heights, was
bitten on his lips on 6 October 1996 by an unidentified animal. On 16 November 1996, he was admitted to the emergency room, and on 15 December 1996, 35 days after clinical symptoms appeared, he died,
despite supportive therapy. The second patient, a 7-year-old girl from
Kalanswa, a village in central Israel, was admitted, unconscious, to
the hospital on 21 November 1997. The only potential exposure to rabies
identified in her case history was a wound that had been inflicted
2 months earlier by an unidentified animal that attacked her in
her sleep. The child died on 7 December 1997, despite supportive care.
The third patient, a 58-year-old man from a northern village,
Judieda, was admitted to the emergency room on 11 December 1997 with a sore throat. It transpired that he had been bitten on his left hand and
face 3 months earlier, while sleeping. The patient died on 16 December
1997. The rabies virus variants isolated from these cases belonged to
three distinct geographical regions: the Golan Heights region, Galilee,
and the Central-Southern region (Fig. 3). The patterns of nucleotide
substitution of the three human isolates, classified in subgroups I A,
II F, and III B, respectively, were identical to those of fox isolates
from the same regions (Fig. 1).
Relationship with foreign rabies virus isolates.
All the
Israeli isolates, the South Lebanon isolate, and the Near-Eastern
variants from Oman, Saudi Arabia, and Iran were closely related.
Israeli rabies virus variants, except variant V, had 98% homology with
the Omani red fox, Saudi Arabian red fox, and Iranian dog and wolf
isolates (Fig. 4). Israeli variant V
differed from other Israeli variants in sharing 97% homology with both
Omani and Saudi Arabian red fox isolates, 96% homology with Iranian
wolf isolates, and 97% homology with Iranian dog isolates. Two
nucleotide substitutions were detected at nucleotide positions 310 (G)
and 313 (T), and these characterized the Middle Eastern isolates (Fig.
5). The Israeli isolates were found to be
more closely related to European isolates (93 to 96% homology) than to
African isolates, e.g., the Egyptian human isolate (90% homology)
(Fig. 4).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Phylogenetic tree produced by Pileup program based on
328-bp sequence of foreign isolates and the Israeli variants. The
foreign isolates included isolates from the African countries Algeria
(U22643), Ethiopia (U22637), Nigeria (U22488), Chad (U22644), and Egypt
(U22627); the European countries France (U22474), Germany (U22475),
Yugoslavia (U22839), Poland (U22840), and Estonia (U22476); and the
Middle-Eastern countries Iran (U22482 and U22483), Oman (U22480), and
Saudi Arabia (U22481). Dg, dog; Hye, hyena; Fx, fox; Wf, wolf; Rac.,
raccoon; Hum., human.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 5.
Sequence analysis of foreign virus isolates and the
Israeli variants. dg, dog; hye, hyena; Fx, fox; wlf, wolf; redfx, red
fox; rac., raccoon; hu, human.
|
|
 |
DISCUSSION |
Molecular epidemiology based on RT-PCR is an important tool for
the classification of animal virus diseases, including rabies virus,
and provides a better understanding of epidemiological relationships
(1, 4). The nucleotide sequence analysis of the 328-bp
fragment of the N gene of isolates from Israel represented the first
epidemiological study done in Israel. In Israel, rabies is region but
not host specific, and isolates are grouped into four geographical
regions. Similar geographical distributions were reported in the
Canadian province of Ontario after PCR and restriction enzyme analysis
of the N gene product (8), and similar studies based on
analysis of a 320-bp fragment have contributed to the epidemiology of
rabies in the United States (12), Venezuela (7),
and Africa (13), while the African wild dog isolates from
the Masai Mara in Kenya were clustered according to the 304-bp sequence
from the N gene (5). Phylogenetic data suitable for compilation of a large epidemiological study were provided by using a
shorter sequence, that of a 200-bp region of the N gene, in a study of
87 isolates collected from areas where dog rabies virus is enzootic in
Asia, Africa, Europe, and the Americas (14). Phylogenetic
analysis of the 93-bp noncoding region corresponding to the 3' end of
the N gene, the intergenic N-NS region, and the 5' end of the NS gene
of 69 rabies virus isolates from various parts of the world facilitated
their geographical classification (6). Nucleotide sequence
analysis of the virus isolates from Israel revealed that differences
between the four groups of variants resided in only one or two
nucleotides. Since mutations in this region of the viral genome are
rare, nucleotide differences between variants can serve as a marker
(16). Rabies variant V, of which two isolates were included
in the present study, differed from the other variants in six
nucleotides. These two variants were isolated from a dog (VI A) and a
cow (VI B) in villages situated along the Israeli borders with Jordan
and Syria, respectively, and it is most likely that they represent
viruses that are prevalent in those countries. An alternative
explanation is that the animals moved from the site where the infection
occurred to a different area, where their infection status was
detected. It was established that foxes serve as a reservoir for rabies
virus in Israel, so geographic boundaries such as mountain ranges and
bodies of water could effectively serve to isolate animal populations;
therefore, geographic parameters might be responsible for the
separate virus populations. The borders of each region are based
on the genetic data presented in this work together with the geographic
features of Israel and the neighboring countries. The Israeli rabies
virus isolates fall into four main geographical regions: the Golan
Heights (region 1), Galilee (region 2), the Central-Southern area
(region 3), and Arava Valley (region 4) (Fig. 3). The Golan
Heights region was bound by the Syrian, Jordan, and Lebanese
borders on three sides, and on the west side, it was bound by the
Jordan River and the Kinerret Lake, which separate regions 1 and 2. The
Galilee region (region 2) is bound by the Lebanese border in
the north and by the Carmel and Gilboa Mountains in the south. The
Central-Southern region (region 3), which is the most populated area,
is bound by the Jordan River and the Negev desert. The Arava
Valley region (region 4), which is the least-populated area, is
bordered by the Jordan border and the Negev desert. Evidence for the
geographical distribution of the Israeli isolates was received from the
molecular and antigenic analysis of the three human isolates. The
results showed that there are three genetic variants, which differed
from each other by one or two nucleotides associated with the three geographic regions. The antigenic characterization of the human isolates revealed two phenotypic variants, 1 and 2, which were distributed in two different geographic regions (2).
Phenotype 1 is distributed in northern and southern Israel, and
phenotype 2 is located in central Israel. Variants from Israel were
very closely related to isolates from the Middle-Eastern countries or
regions of South Lebanon, Iran, Oman, and Saudi Arabia (Fig. 4). Recent
molecular studies showed differences between isolates from Europe,
Asia, the Americas, and Africa (6, 14), while a close
relationship was found between isolates from Middle-Eastern and
European countries, though they differed from isolates of Asian and
African countries (6). The genetically close relationship between isolates from European and Middle-Eastern countries suggests that the viruses circulating in foxes in both these regions might have
the same origin; nevertheless, it seems that the 2-nucleotide substitution is a specific genomic marker for rabies virus isolates found in Middle-Eastern countries.
 |
ACKNOWLEDGMENTS |
We thank C. E. Rupprecht from the National Center for
Infectious Diseases, Atlanta, Ga., for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Rabies
Laboratory, Pathology Division, Kimron Veterinary Institute, P.O. Box
12, Bet Dagan 50250, Israel. Phone: 972-3-9681727. Fax: 972-3-9681753. E-mail: ddavi_vs{at}netvision.net.il.
 |
REFERENCES |
| 1.
|
Boury, H.,
B. Kissi,
N. Tordo,
H. Badrane, and D. Sacramento.
1995.
Molecular epidemiology tools and phylogenetic analysis of bacteria and viruses with special emphasis on lyssaviruses.
Prev. Vet. Med.
25:164-181.
|
| 2.
|
David, D.,
C. E. Rupprecht,
J. S. Smith,
I. Samina,
S. Perl, and Y. Stram.
1999.
Human rabies in Israel.
Emerg. Infect. Dis.
5:306-308[Medline].
|
| 3.
|
Genetics Computer Group.
1995.
Program manual for the Genetics Computer Group package, version 7.575.
Genetics Computer Group, Madison, Wis.
|
| 4.
|
Haas, L.
1997.
Molecular epidemiology of animal virus disease.
J. Vet. Med. Ser. B
44:257-272.
|
| 5.
|
Kat, P. W.,
K. A. Alexander,
J. S. Smith,
J. D. Richardson, and L. Munson.
1996.
Rabies among African wild dog (Lycaon pictus) in the Masai Mara, Kenya.
J. Vet. Diagn. Investig.
8:420-426[Abstract/Free Full Text].
|
| 6.
|
Kissi, B.,
N. Tordo, and H. Bourhy.
1995.
Genetic polymorphism in the rabies virus nucleoprotein gene.
Virology
209:526-537[CrossRef][Medline].
|
| 7.
|
Mattos, C. A.,
C. C. Mattos,
J. S. Smith,
E. T. Miller,
S. Papo,
A. Utrera, and B. I. Osburn.
1996.
Genetic characterization of rabies field isolates from Venezuela.
J. Clin. Microbiol.
34:1553-1558[Abstract].
|
| 8.
|
Nadin-Davis, S. A.,
G. A. Casey, and A. Wandeler.
1993.
Identification of regional variants of the rabies virus within the Canadian province of Ontario.
J. Gen. Virol.
74:829-837[Abstract/Free Full Text].
|
| 9.
|
Nobel, T. A., and F. Neumann.
1962.
Laboratory diagnosis of rabies in Israel, 1949-1961.
Refu. Vet.
19:116-122.
|
| 10.
|
Smith, J. S.
1995.
Rabies virus, p. 907-1003.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 11.
|
Smith, J. S., and H. D. Seidel.
1993.
Rabies: a new look at an old disease.
Prog. Med. Virol.
40:82-106[Medline].
|
| 12.
|
Smith, J. S.
1996.
New aspects of rabies emphasis on epidemiology, diagnosis and prevention of the disease in the United States.
Clin. Microbiol. Rev.
9:166-176[Medline].
|
| 13.
|
Smith, J. S.,
P. A. Yager, and L. A. Orciari.
1993.
Rabies in wild and domestic carnivores of Africa: epidemiological and historical associations determined by limited sequence analysis.
Onderstepoort J. Vet. Res.
60:307-314[Medline].
|
| 14.
|
Smith, J. S.,
H. D. Seidel, and C. K. Warner.
1992.
Epidemiology and historical relationships among 87 rabies virus isolates determined by limited sequence analysis.
J. Infect. Dis.
166:296-307[Medline].
|
| 15.
|
Tordo, N.,
O. Poch,
A. Ermine,
G. Keith, and F. Rougeon.
1986.
Walking along the rabies genome is the G-L intergenic region a remnant gene?
Proc. Natl. Acad. Sci. USA
83:3914-3918[Abstract/Free Full Text].
|
| 16.
|
Tordo, N.,
O. Poch,
A. Ermine, and G. Keith.
1986.
Primary structure of leader RNA and nucleoprotein genes of the rabies genome: segmented homology with VSV.
Nucleic Acids Res.
14:2671-2683[Abstract/Free Full Text].
|
| 17.
|
Yakobson, B.,
D. L. Manalo,
K. Bader,
S. Perl,
A. Haber,
B. Shahimov, and N. Shechat.
1998.
An epidemiological retrospective study of rabies diagnosis and control in Israel 1948-1997.
Isr. J. Vet. Med.
53:114-127.
|
Journal of Clinical Microbiology, February 2000, p. 755-762, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
David, D., Hughes, G. J., Yakobson, B. A., Davidson, I., Un, H., Aylan, O., Kuzmin, I. V., Rupprecht, C. E.
(2007). Identification of novel canine rabies virus clades in the Middle East and North Africa. J. Gen. Virol.
88: 967-980
[Abstract]
[Full Text]
-
Nasereddin, A., Baneth, G., Schonian, G., Kanaan, M., Jaffe, C. L.
(2005). Molecular Fingerprinting of Leishmania infantum Strains following an Outbreak of Visceral Leishmaniasis in Central Israel. J. Clin. Microbiol.
43: 6054-6059
[Abstract]
[Full Text]
-
Kuzmin, I. V., Botvinkin, A. D., McElhinney, L. M., Smith, J. S., Orciari, L. A., Hughes, G. J., Fooks, A. R., Rupprecht, C. E.
(2004). MOLECULAR EPIDEMIOLOGY OF TERRESTRIAL RABIES IN THE FORMER SOVIET UNION. J Wildl Dis
40: 617-631
[Abstract]
[Full Text]
-
East, M. L., Hofer, H., Cox, J. H., Wulle, U., Wiik, H., Pitra, C.
(2001). Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas. Proc. Natl. Acad. Sci. USA
10.1073/pnas.261411898v1
[Abstract]
[Full Text]
-
East, M. L., Hofer, H., Cox, J. H., Wulle, U., Wiik, H., Pitra, C.
(2001). Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas. Proc. Natl. Acad. Sci. USA
98: 15026-15031
[Abstract]
[Full Text]